Halley E. Gilbert - Jun 3, 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Jun 3, 2024
Transactions value $
-$1,231,230
Form type
4
Date filed
6/5/2024, 04:59 PM
Previous filing
May 17, 2024
Next filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $97.4K +18.2K +323.56% $5.35* 23.8K Jun 3, 2024 Direct
transaction PCVX Common Stock Sale -$1.33M -18.2K -76.39% $73.00 5.63K Jun 3, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Options Exercise $0 -18.2K -37.47% $0.00 30.4K Jun 3, 2024 Common Stock 18.2K $5.35 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024.
F2 Option is fully vested and exercisable.
F3 Reporting Person has transferred 30,374 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings.